Reappraisal of the optic nerve hypoplasia syndrome

Journal of Neuro-Ophthalmology

Volumn 32, Issue 1, 2012, Pages 58-67

  Borchert, Mark ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENT SEPTUM PELLUCIDUM; AUTISM; BRAIN MALFORMATION; CONGENITAL BLINDNESS; CORPUS CALLOSUM AGENESIS; CORTICAL HETEROTOPIA; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; GYRUS DYSPLASIA; HETEROTOPIA; HISTORY OF MEDICINE; HUMAN; HYPOPITUITARISM; HYPOTHALAMUS DISEASE; MEDICAL LITERATURE; NEUROIMAGING; OPTIC NERVE DISEASE; OPTIC NERVE HYPOPLASIA SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEPTOOPTIC DYSPLASIA; SEPTUM PELLUCIDUM;

BLINDNESS; CEREBRUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOPITUITARISM; NERVOUS SYSTEM MALFORMATIONS; OPTIC NERVE; SEPTO-OPTIC DYSPLASIA; SEPTUM PELLUCIDUM; SYNDROME;

EID: 84857813162     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31824442b8     Document Type: Review

References (83)

1. Briere W. Absence des papiller, cecite absolue. Ann Ocul. 1877;78:41-42.
2. Schwarz O. Ein Fall von mangelhafter Bildung beider Sehnerven. Albrecth von Graefes Arch Klin Ophthalmol. 1915;90:326-328.
3. Reeves D. Congenital absence of the septum pellucidum. Bull Johns Hopkins Hosp. 1941;69:61-71.
4. Straatsma BS. S. Rodman Irvine, MD. Trans Am Ophthalmol Soc. 2000;98:9-10.
5. de Morsier G. Etudes sur les dysraphies cranio-encephaliques: Agenesis du septum lucidum avec malformation du tractus optique. La dysplasie septo-optique. Schweiz Arch Neurol Psychiatr. 1956;77:267-292.
6. De Morsier G. Median cranioencephalic dysraphias and olfactogenital dysplasia. World Neurology. 1962;3:485-504.
7. Gross H, Hoff H. Sur les malformations ventruculaires dependantes des dysgenesies commisurales. In: Heuyer G, Feld M, Gruner J, eds. Malformations congentales du cerveau. Paris, France: Masson, 1959:329-351.
8. Ellenberger C, Runyan TE. Holoprosencephaly with hypoplasia of the optic nerves, dwarfism, and agenesis of the septum pellucidum. Am J Ophthalmol. 1970;70:960-967.
9. Hoyt WF, Kaplan SL, Grumbach MM, Glaser JS. Septo-optic dysplasia and pituitary dwarfism. Lancet. 1970;1:893-894.
10. Hedges TR. Charles Bonnet, his life, and his syndrome. Surv Ophthalmol. 2007;52:111-114.
11. Blohme J, Tornqvist K. Visual impairment in Swedish children. III. Diagnoses. Acta Ophthalmol Scand. 1997;75:681-687.
12. Blohme J, Bengtsson-Stigmar E, Tornqvist K. Visually impaired Swedish children. Longitudinal comparisons 1980-1999. Acta Ophthalmol Scand. 2000;78:416-420.
13. Patel L, McNally R, Harrison E, Lloyd IC, Clayton PE. Geographical distribution of optic nerve hypoplasia and septooptic dysplasia in Northwest England. J Pediatr. 2006;148:85-88.
14. Jan J, Robinson G, Kinnis C, McLeod PJ. Blindness due to optic-nerve atrophy and hypoplasia in children: An epidemiological study (1944-1974). Dev Med Child Neurol. 1977;19:353-363.
15. Acers TE. Optic nerve hypoplasia: Septo-optic-pituitary dysplasia syndrome. Trans Am Ophthalmol Soc. 1981;79:425-457.
16. Williamson WD, Desmond MM, Andrew LP, Hicks RN. Visually impaired infants in the 1980s. A survey of etiologic factors and additional handicapping conditions in a school population. Clin Pediatr. 1987;26:241-244.
17. DeCarlo DK, Nowakowski R. Causes of visual impairment among students at the Alabama School for the Blind. J Am Optom Assoc. 1999;70:647-652.
18. Mets MB. Childhood blindness and visual loss: An assessment at two institutions including a "new" cause. Trans Am Ophthalmol Soc. 1999;97:653-696.
19. Hatton D, Schwietz E, Boyer B, Rychwalski P. Babies Count: The national registry for children with visual impairments, birth to 3 years. J AAPOS. 2007;11:351-355.
20. Birkebaek N, Patel L, Wright NB, Grigg JR, Sinha S, Hall CM, Price DA, Lloyd IC, Clayton PE. Endocrine status in patients with optic nerve hypoplasia: Relationship to midline central nervous system abnormalities and appearance of the hypothalamic-pituitary axis on magnetic resonance imaging. J Clin Endocrinol Metab. 2003;88:5281-5286.
21. Patel H, Tze WJ, Crichton JU, McCormick AQ, Robinson GC, Dohnan CL. Optic nerve hypoplasia with hypopituitarism. Septo-optic dysplasia with hypopituitarism. Am J Dis Child. 1975;129:175-180.
22. Williams J, Brodsky MC, Griebel M, Glasier CM, Caldwell D, Thomas P. Septo-optic dysplasia: The clinical insignificance of an absent septum pellucidum. Dev Med Child Neurol. 1993;35:490-501.
23. Wilson DM, Enzmann DR, Hintz RL, Rosenfeld G. Computed tomographic findings in septo-optic dysplasia: Discordance between clinical and radiological findings. Neuroradiology. 1984;26:279-283.
24. Brodsky MC, Glasier CM. Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Arch Ophthalmol. 1993;111:66-74.
25. Ahmad T, Garcia-Filion P, Borchert M, Kaufman F, Burkett L, Geffner M. Endocrinological and auxological abnormalities in young children with optic nerve hypoplasia: A prospective study. J Pediatr. 2006;148:78-84.
26. Garcia-Filion P, Epport K, Nelson M, Azen C, Geffner ME, Fink C, Borchert M. Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: A prospective study. Pediatrics. 2008;121:e653-e659.
27. Miller SP, Shevell MI, Patenaude Y, Poulin C, O'Gorman AM. Septo-optic dysplasia plus: A spectrum of malformations of cortical development. Neurology. 2000;54:1701-1703.
28. Glass HC, Shaw GM, Ma C, Sherr EH. Agenesis of the corpus callosum in California 1983-2003: A population-based study. Am J Med Genet A. 2008;146A:2495-2500.
29. Szabó N, Gergev G, Kobor J, Bereg E, Turi S, Sztriha L. Corpus callosum anomalies: Birth prevalence and clinical spectrum in Hungary. Pediatr Neurol. 2011;44:420-426.
30. Schell-Apacik CC, Wagner K, Bihler M, Erti-Wagner B, Heinrich U, Klopocki E, Kalscheuer VM, Muenke M, vonVoss H. Agenesis and dysgenesis of the corpus callosum: Clinical, genetic and neuroimaging findings in a series of 41 patients. Am J Med Genet A. 2008;146A:2501-2511.
31. Phillips PH, Spear C, Brodsky MC. Magnetic resonance diagnosis of congenital hypopituitarism in children with optic nerve hypoplasia. J AAPOS. 2001;5:275-280.
32. Kucharczyk W, Lenkinski RE, Kucharczyk J, Henkelman RM. The effect of phospholipid vesicles on the NMR relaxation of water: An explanation for the MR appearance of the neurohypophysis? AJNR Am J Neuroradiol. 1990;11:693-700.
33. Birkebaek NH, Patel L, Wright NB, Grigg JR, Sinha S, Hall CM, Price DA, Lloyd IC, Clayton PE. Optic nerve size evaluated by magnetic resonance imaging in children with optic nerve hypoplasia, multiple pituitary hormone deficiency, isolated growth hormone deficiency, and idiopathic short stature. J Pediatr. 2004;145:536-541.
34. Hellström A, Wiklund LM, Svensson E. Diagnostic value of magnetic resonance imaging and planimetric measurement of optic disc size in confirming optic nerve hypoplasia. J AAPOS. 1999;3:104-108.
35. Brodsky MC, Glasier CM, Pollock SC, Angtuago EJ. Optic nerve hypoplasia: Identification by magnetic resonance imaging. Arch Ophthalmol. 1990;108:1562-1567.
36. Hellstrom A, Svensson E, Carlsson B, Niklasson A, Albertsson-Wikland K. Reduced retinal vascularization in children with growth hormone deficiency. J Clin Endocrinol Metab. 1999;84:795-798.
37. Mosier MA, Lieberman MF, Green WR, Knox DL. Hypoplasia of the optic nerve. Arch Ophthalmol. 1978;96:1437-1442.
38. Borchert M, McCulloch D, Rother C, Stout AU. Clinical assessment, optic disk measurements, and visual-evoked potential in optic nerve hypoplasia. Am J Ophthalmol. 1995;120:605-612.
39. Zeki SM, Dudgeon J, Dutton GN. Reappraisal of the ratio of disc to macula/disc diameter in optic nerve hypoplasia. Br J Ophthalmol. 1991;75:538-541.
40. McCulloch DL, Garcia-Filion P, Fink C, Chaplin CA, Borchert MS. Clinical electrophysiology and visual outcome in optic nerve hypoplasia. Br J Ophthalmol. 2010;94:1017-1023.
41. De Silva DJ, Cocker KD, Lau G, Clay ST, Fielder AR, Moseley MJ. Optic disk size and optic disk-to-fovea distance in preterm and full-term infants. Invest Ophthalmol Vis Sci. 2006;47:4683-4686.
42. Srinivasan G, Venkatesh P, Garg S. Optic nerve head, retinal nerve fiber layer, and macular thickness characteristics on optical coherence tomography in optic disk hypoplasia. J Pediatr Ophthalmol Strabismus. 2007;44:140-141.
43. Jacobson L, Hellstrom A, Flodmark O. Large cups in normalsized optic discs: A variant of optic nerve hypoplasia in children with periventricular leukomalacia. Arch Ophthalmol. 1997;115:1263-1269.
44. Brodsky MC. Periventricular leukomalacia: An intracranial cause of pseudoglaucomatous cupping. Arch Ophthalmol. 2001;119:626-627.
45. Siatkowski R, Sanchez J, Andrade R, Alvarez A. The clinical, neuroradiographic, and endocrinologic profile of patients with bilateral optic nerve hypoplasia. Ophthalmology. 1997;104:493-496.
46. Magoon EH, Robb RM. Development of myelin in human optic nerve and tract. A light and electron microscopic study. Arch Ophthalmol. 1981;99:655-659.
47. Reidl S, Mullner-Eidenbock A, Prayer D, Bernert G, Frisch H. Auxological, ophthalmological, neurological and MRI findings in 25 Austrian patients with septo-optic dysplasia (SOD). Horm Res. 2002;58(suppl 3):16-19.
48. Haddad NG, Eugster EA. Hypopituitarism and neurodevelopmental abnormalities in relation to central nervous system structural defects in children with optic nerve hypoplasia. J Pediatr Endocrinol Metab. 2005;18:853-858.
49. Ma NS, Geffner ME, Borchert M. Evolving central hypothyroidism in children with optic nerve hypoplasia. J Pediatr Endocrinol Metab. 2010;23:53-58.
50. Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav. 2001;74:703-708.
51. Moore RY. Circadian rhythms: Basic neurobiology and clinical applications. Annu Rev Med. 1997;48:253-266.
52. Panda S, Hogenesch JB, Kay SA. Circadian rhythms from flies to human. Nature. 2002;417:329-335.
53. Weaver DR. The suprachiasmatic nucleus: A 25-year retrospective. J Biol Rhythms. 1998;13:100-112.
54. Edgar DM, Dement WC, Fuller CA. Effect of SCN lesions on sleep in squirrel monkeys: Evidence for opponent processes in sleep-wake regulation. J Neurosci. 1993;13:1065-1079.
55. Moore-Ede MC, Czeisler CA, Richardson GS. Circadian timekeeping in health and disease. Part 1. Basic properties of circadian pacemakers. N Engl J Med. 1983;309:469.
56. Rivkees SA. Arrhythmicity in a child with septo-optic dysplasia and establishment of sleep-wake cyclicity with melatonin. J Pediatr. 2001;139:463-465.
57. Rivkees S, Fink C, Nelson M, Borchert M. Prevalence and risk factors for disrupted circadian rhythmicity in children with optic nerve hypoplasia. Br J Ophthalmol. 2010;94:1358-1362.
58. Scammell TE, Elmquist JK, Griffin JD, Saper CB. Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways. J Neurosci. 1996;16:6246-6254.
59. McMahon C, Braddock S. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. Teratology. 2001;64:83-86.
60. Margalith D, Jan JE, McCormick AQ, Tze WJ, Lapointe J. Clinical spectrum of optic nerve hypoplasia: A review of 51 patients. Dev Med Child Neurol. 1984;26:311-322.
61. Burke J, O'Keefe M, Bowell R. Optic nerve hypoplasia, encephalopathy, and neurodevelopmental handicap. Br J Ophthalmol. 1991;75:236-239.
62. Garcia ML, Ty EB, Taban M, David Rothner A, Rogers D, Traboulsi EI. Systemic and ocular findings in 100 patients with optic nerve hypoplasia. J Child Neurol. 2006;21:949-956.
63. Griffiths P, Hunt S. Specific spatial defect in a child with septooptic dysplasia. Dev Med Child Neurol. 1984;26:395-400.
64. Brown R, Hobson RP, Lee A, Stevenson J. Are there " autisticlike" features in congenitally blind children? J Child Psychol Psychiat. 1997;36:693-703.
65. Ek U, Fernell E, Jacobson L. Cognitive and behavioural characteristics in blind children with bilateral optic nerve hypoplasia. Acta Paediatrica. 2005;94:1421-1426.
66. Parr JR, Dale NJ, Shaffer LM, Salt AT. Social communication difficulties and autism spectrum disorder in young children with optic nerve hypoplasia and/or septo-optic dysplasia. Dev Med Child Neurol. 2010;52:917-921.
67. Tajima T, Hattorri T, Nakajima T, Okuhara K, Sato K, Abe S, Nakae J, Fujieda K. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab. 2003;88:45-50.
68. Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Hum Genet. 2010;18:393-397.
69. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC. Mutations in the homeobox gene HESX1/Hesx1 associate with septo-optic dysplasia in human and mouse. Nat Genet. 1998;19:125-133.
70. McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, Keller E, Keller A, Haufs N, Krude H, Shalet SM, Dattani MT. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab. 2007;92:691-697.
71. Mellado C, Poduri A, Gleason D, Elhosary PC, Barry BJ, Partlow JN, Chang BS, Shaw GM, Barkovitch AJ, Walsh CA. Candidate gene sequencing of LHX2, Hesx1, and SOX2 in a large schizencephaly cohort. Am J Med Genet A. 2010;1562A:2736-2742.
72. Hackenbruch Y, Meerhoff E, Besio R, Cardoso H. Familial bilateral optic nerve hypoplasia. Am J Ophthalmol. 1975;79:314-320.
73. Tornqvist K, Ericsson A, Kallen B. Optic nerve hypoplasia: Risk factors and epidemiology. Acta Ophthalmol Scand. 2002;80:300-304.
74. Murray PG, Paterson WF, Donaldson MD. Maternal age in patients with septo-optic dysplasia. J Pediatr Endocrinol Metab. 2005;18:471-476.
75. Hoyt C, Billson F. Maternal anti-convulsants and optic nerve hypoplasia. Br J Ophthalmol. 1978;62:3-6.
76. Hotchkiss M, Green W. Optic nerve aplasia and hypoplasia. J Pediatr Ophthalmol Strabismus. 1979;16:225-240.
77. West J, Burke J, Strachan I. Carbamazepine, epilepsy, and optic nerve hypoplasia. Br J Ophthalmol. 1990;74:511.
78. Hellstrom A, Wiklund L, Svensson E. The clinical and morphological spectrum of optic nerve hypoplasia. J AAPOS. 1999;3:212-220.
79. Hittner H, Desmond M, Montgomery J. Optic nerve manifestations of cyto-megalovirus infection. Am J Ophthalmol. 1976;81:661-665.
80. Stromland K. Ocular involvement in the fetal alcohol syndrome. Surv Ophthalmol. 1987;31:277-284.
81. Ribeiro IM, Vale PJ, Tenedorio PA, Rodrigues PA, Bilhoto MA, Pereira HC. Ocular manifestations in fetal alcohol syndrome. Eur J Ophthalmol. 2007;17:104-109.
82. Roberts-Harry J, Green S, Willshaw H. Optic nerve hypoplasia: Associations and management. Arch Dis Child. 1990;65:103-106.
83. Garcia-Filion P, Fink C, Geffner M, Borchert M. Optic nerve hypoplasia in North America: A re-appraisal of perinatal risk factors. Acta Ophthalmol Scand. 2010;88:527-534.